Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents

机译：利巴韦林和直接作用抗病毒药治疗的慢性丙型肝炎患者贫血的预测因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

ObjectivesAnaemia is the most common side effect associated with ribavirin (RBV). This study intended to assess its incidence and determine its predictive factors in patients with hepatitis C virus on RBV plus direct-acting antiviral agents (DAAs).

机译：目的贫血是与病毒唑（RBV）相关的最常见的副作用。这项研究旨在评估RBV加上直接作用抗病毒药物（DAA）的丙型肝炎病毒患者的发病率并确定其预测因素。

著录项

期刊名称 European Journal of Hospital Pharmacy
作者
Emilio Molina-Cuadrado; Héctor Mateo-Carrrasco; Antonio Collado; Marta Casado Martín;
展开▼
作者单位

展开▼
年(卷),期 2018(25),3
年度 2018
页码 132–137
总页数 6
原文格式 PDF
正文语种
中图分类药学;
关键词
Ribavirin Direct-acting antiviral Anaemia Predictor Hepatitis C;

机译：利巴韦林;直接作用抗病毒药;贫血;预测因子;丙型肝炎;

相似文献

外文文献
中文文献
专利

1. Ribavirin plasma level is an independent predictor for sustained virologic response in difficult to treat hepatitis C-infected patients treated with direct-acting antivirals plus ribavirin combination (HepNed study 002) [J] . Lieveld Faydra I., van Tilborg Marjolein, Smolder Elise J., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：利巴韦林血浆水平是难以治疗用直接作用抗病毒药肽加密素组合治疗的丙型肝炎C感染患者持续的病毒性反应的独立预测因素（Hepned研究002）
2. Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings [J] . Chen Cheng-Pin, Cheng Chien-Yu, Zou Huachun, Journal of microbiology, immunology, and infection: Wei mian yu gan ran za zhi . 2019,第4期

机译：评价PEGINTERFEREN PRIBAVIRIN在监狱和社区环境中艾滋病毒感染患者慢性丙基肝炎治疗和直接作用抗病毒剂的评价
3. Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antivirals [J] . van Tilborg M., Lieveld F. I., Smolders E. J., Alimentary pharmacology & therapeutics. . 2017,第9期

机译：利巴韦林稳态等离子体水平是丙型肝炎C感染患者持续的病毒学反应的预测因子，该患者治疗直接作用抗病毒症
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. Analyzing the Impact of the CMS Guidance on Assuring Access to Hepatitis C Virus (HCV) Drugs on Utilization of Direct-Acting Antiviral (DAA) Agents [D] . Ferrell, Kelli Walker. 2017

机译：分析CMS指南对确保获得丙型肝炎病毒（HCV）药物对直接作用抗病毒（DAA）药物利用的影响
6. Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents [O] . Giovanni Damiani, Chiara Franchi, Paolo Pigatto, 2018

机译：与新型直接作用抗病毒药相比聚乙二醇干扰素联合利巴韦林治疗丙型肝炎病毒阳性银屑病患者的结果评估
7. Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals [O] . Viola Guardigni, Lorenzo Badia, Matteo Conti, 2017

机译：肝脏失代偿预测直接作用抗病毒治疗的丙型肝炎病毒患者中的利巴韦林过度曝光

Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅